UGM

UGM is an Argentine drugmaker that is the subject of a corporate acquisition, as Megalabs plans to buy a stake in the company.

Why it’s in the news: UGM is in the news because of the announced acquisition by Megalabs.

Latest on UGM

• STAT+: Justice Department targets drugmakers in new directive on combating white-collar fraud
• Weight-loss drugs show signs of slowing biological aging, say drugmakers
• STAT+: Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments
• Megalabs to buy stake in Argentine drugmaker
• TechCrunch Disrupt 2026 Side Events schedule: NMI, Backblaze, PeakXV Partners, Augment, and more to host
• Snap targets enterprises with Salesforce, Nvidia AI tools for augmented-reality glasses

Connections

3 entities linked to UGM across the news graph.